Total distances covered by PD mice treated with PF, SP600125 (a specific JNK inhibitor), and PF+SP600125 was significantly higher relative to untreated PD mice (p=<0.001, p=<0.01, p=<0.001, Figure 3A, D). Here, MAPK8 is linked to Parkinson disease.